Review: The importance of residual endogenous beta-cell preservation in type 1 diabetes

Alhadj Ali, Mohammad ORCID: https://orcid.org/0000-0002-9780-6443 and Dayan, Colin M. ORCID: https://orcid.org/0000-0002-6557-3462 2009. Review: The importance of residual endogenous beta-cell preservation in type 1 diabetes. British Journal of Diabetes and Vascular Disease 9 (6) , pp. 248-253. 10.1177/1474651409351881

Full text not available from this repository.

Abstract

Achieving tight glycaemic control in type 1 diabetes remains very challenging for patients. However, some individuals retain a degree of endogenous beta-cell function for 5 or more years after diagnosis, and prospective studies confirm that this is associated not only with lower glycated haemoglobin A1c levels, and less hypoglycaemia, but also a reduced incidence of long-term complications. An independent effect of insulin C-peptide may contribute to this beneficial effect. Retention of even small amounts of endogenous beta-cell function for as long as possible should therefore be a key therapeutic goal in type 1 diabetes. Tight glycaemic control from diagnosis has already been shown to help in this regard, and we argue that the introduction of novel immunotherapies which achieve this important goal should be strongly encouraged, even if they fall short of an insulin-free 'cure'.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	SAGE Publications (UK and US)
ISSN:	1474-6514
Last Modified:	09 Nov 2022 09:28
URI:	https://orca.cardiff.ac.uk/id/eprint/135852

Citation Data

Cited 16 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item